Promega Corporation

Caspase-3 Identified as the Key Biomarker for Apoptosis

Promega Homogeneous Bioluminescent Caspase Assays simplify apoptosis detection and are up to 50-100 times more sensitive than competitive caspase technologies. Now, detect caspase-3/7, -8, -9, -2 and -6 activities in multiwell plates using less cells or enzyme and get faster throughput, with same-well multiplexing capability to determine the mechanism of cell death.

Download our Cell Based Assays video.
Closed Format: MP4
Open Format: OGG

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.

Click Here for Technical Questions and Ordering Support »